Edgar Lomax Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51.4M | Sell |
715,960
-196,740
| -22% | -$15.2M | 3.67% | 6 |
|
|
2025
Q4 | $72.4M | Sell |
912,700
-20,865
| -2% | -$1.64M | 5.5% | 1 |
|
|
2025
Q3 | $70.4M | Sell |
933,565
-273,260
| -23% | -$18.7M | 5.51% | 1 |
|
|
2025
Q2 | $83.2M | Sell |
1,206,825
-19,410
| -2% | -$1.27M | 5.27% | 1 |
|
|
2025
Q1 | $83.1M | Buy |
1,226,235
+339,405
| +38% | +$20.3M | 5.2% | 1 |
|
|
2024
Q4 | $39.8M | Sell |
886,830
-13,615
| -2% | -$764K | 2.57% | 14 |
|
|
2024
Q3 | $56.6M | Sell |
900,445
-14,235
| -2% | -$830K | 3.46% | 6 |
|
|
2024
Q2 | $54M | Sell |
914,680
-15,155
| -2% | -$948K | 3.5% | 7 |
|
|
2024
Q1 | $74.2M | Buy |
929,835
+363,391
| +64% | +$27.8M | 4.58% | 3 |
|
|
2023
Q4 | $44.7M | Sell |
566,444
-25,255
| -4% | -$1.8M | 2.92% | 12 |
|
|
2023
Q3 | $41.3M | Sell |
591,699
-9,835
| -2% | -$697K | 2.81% | 14 |
|
|
2023
Q2 | $41.6M | Sell |
601,534
-8,211
| -1% | -$584K | 2.74% | 13 |
|
|
2023
Q1 | $45.3M | Sell |
609,745
-210,455
| -26% | -$17.6M | 2.91% | 12 |
|
|
2022
Q4 | $76.4M | Sell |
820,200
-4,775
| -0.6% | -$461K | 4.64% | 3 |
|
|
2022
Q3 | $78.7M | Sell |
824,975
-9,090
| -1% | -$900K | 5.44% | 1 |
|
|
2022
Q2 | $77.3M | Buy |
834,065
+20,855
| +3% | +$2.04M | 4.84% | 4 |
|
|
2022
Q1 | $82.3M | Sell |
813,210
-103,515
| -11% | -$10.9M | 4.83% | 2 |
|
|
2021
Q4 | $94.6M | Sell |
916,725
-8,825
| -1% | -$815K | 5.66% | 1 |
|
|
2021
Q3 | $78.5M | Sell |
925,550
-15,789
| -2% | -$1.32M | 5.04% | 2 |
|
|
2021
Q2 | $78.5M | Sell |
941,339
-35,526
| -4% | -$2.91M | 4.88% | 2 |
|
|
2021
Q1 | $73.5M | Buy |
+976,865
| New | +$71.2M | 4.58% | 3 |
|
|
2019
Q1 | – | Sell |
-888,433
| Closed | -$58.2M | – | 66 |
|
|
2018
Q4 | $58.2M | Sell |
888,433
-26,250
| -3% | -$1.96M | 4.42% | 5 |
|
|
2018
Q3 | $72M | Sell |
914,683
-32,050
| -3% | -$2.29M | 4.83% | 3 |
|
|
2018
Q2 | $60.9M | Buy |
946,733
+7,250
| +0.8% | +$478K | 4.28% | 4 |
|
|
2018
Q1 | $58.4M | Buy |
939,483
+291,375
| +45% | +$20.9M | 4.2% | 4 |
|
|
2017
Q4 | $47M | Sell |
648,108
-19,245
| -3% | -$1.4M | 3.21% | 12 |
|
|
2017
Q3 | $54.3M | Sell |
667,353
-56,892
| -8% | -$4.5M | 3.83% | 5 |
|
|
2017
Q2 | $58.3M | Sell |
724,245
-20,750
| -3% | -$1.64M | 3.98% | 6 |
|
|
2017
Q1 | $58.5M | Buy |
744,995
+733,795
| +6,552% | +$58.6M | 3.92% | 7 |
|
|
2016
Q4 | $884K | Buy |
+11,200
| New | +$906K | 0.06% | 55 |
|
|
2014
Q1 | – | Sell |
-703,906
| Closed | -$50.4M | – | 62 |
|
|
2013
Q4 | $50.4M | Buy |
703,906
+125,100
| +22% | +$8.04M | 3.81% | 6 |
|
|
2013
Q3 | $32.8M | Sell |
578,806
-54,200
| -9% | -$3.23M | 2.69% | 11 |
|
|
2013
Q2 | $36.2M | Buy |
+633,006
| New | +$36.7M | 2.82% | 12 |
|
Other funds holding CVS
VCM
VPM
Edgar Lomax Company's CVS Position: Q1 2026 in Review
Edgar Lomax Company reduced its CVS Health (CVS) stake by 22% in Q1 2026, selling an estimated $15.2M and leaving 715,960 shares worth $51.4M. The position accounts for 3.67% of the portfolio, ranked #6.
Edgar Lomax Company first reported a position in CVS in Q2 2013 and has held it in 33 quarters since. The position peaked at $94.6M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Edgar Lomax Company held 715,960 shares of CVS Health worth $51.4M as of Q1 2026.
- Edgar Lomax Company sold 196,740 CVS Health shares in Q1 2026, an estimated $15.2M.
- CVS Health made up 3.67% of Edgar Lomax Company's portfolio in Q1 2026, its #6 holding.
- Edgar Lomax Company first reported a position in CVS Health in Q2 2013 and has held it in 33 quarters since.
- Edgar Lomax Company's CVS Health position peaked at $94.6M in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Edgar Lomax Company's 13F filing for Q1 2026, filed 12 May 2026.